Pembrolizumab trials for Metastatic Colorectal Cancer

All Pembrolizumab trials · All Metastatic Colorectal Cancer trials

Phase breakdown

Recruiting trials studying Pembrolizumab for Metastatic Colorectal Cancer

• A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
  NCT07255664 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer
  NCT05462236 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
  NCT05725200 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Pembrolizumab for Metastatic Colorectal Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.